This webinar explores the evolving role of prostatic stents in the management of benign prostatic hyperplasia (BPH), focusing on appropriate patient selection and clinical indications. The session will cover procedural techniques, device options, and practical considerations for stent placement and removal. Experts will discuss short- and long-term outcomes, complication profiles, and comparison with medical and surgical alternatives. Real-world case experiences will highlight decision-making in complex or high-risk patients. Designed for urologists and healthcare professionals, this webinar aims to provide evidence-based guidance for integrating BPH stents into clinical practice.
Chief of Urology, Plainview Hospital, Associate Professor of Urology, Donald and Barbara Zucker School of Medicine, New York, United States
Dr. Bilal Chugtai is the Chief of Urology at Plainview Hospital and an Associate Professor of Urology at the Donald and Barbara Zucker School of Medicine, New York, United States. He is a nationally recognized urologist with extensive expertise in benign prostatic hyperplasia, minimally invasive urologic procedures, and men’s health. Dr. Chugtai is actively involved in clinical research and has authored numerous peer-reviewed publications contributing to advances in urologic care. He is also deeply committed to medical education and mentoring the next generation of urologists. His work bridges academic excellence with high-quality, patient-centered clinical practice.